Actionnariat et activité des initiés pour Kazia Therapeutics Ltd ADR (KZIA): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $10.20 |
| Capitalisation | $17M |
| Bourse | NASDAQ |
| Pays | AU |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-01-08 | Coffey Steven R. S. | A-Award | 100,000 | $910K |
| 2026-01-08 | Friend John E. II | A-Award | 500,000 | $3.4M |
| 2026-01-08 | Friend John E. II | A-Award | 150,000 | |
| 2026-01-08 | Bonacorda Jeffrey | A-Award | 150,000 | $1.0M |
| 2026-01-08 | Davidson Ebru | A-Award | 100,000 | $910K |
| 2026-01-08 | Cain David | A-Award | 100,000 | $910K |
| 2026-01-08 | APPLE ROBERT F | A-Award | 75,000 | $508K |
| 2026-06-19 | Levine James E. | A-Award | 200,000 | $2.8M |
| 2026-06-19 | Rao Sudha | A-Award | 250,000 | $4.6M |
| 2026-06-01 | Levine James E. |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $33.5M | $14.5M | $6.0M | $5.4M | $8.8M | $27.6M | $7.4M | $5.2M | $1.7M | $4.3M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Créances | $91000 | $5067 | $1130 | $1.6M | $439 | 0 | $51000 | $105000 | $133000 | $90000 |
| Stocks | $434000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $34.1M | $19.5M | $9.3M | $7.5M | $10.7M | $29.4M | $9.4M | $10.8M | $6.1M | $4.9M |
| Immobilisations Corporelles | $592000 | $489605 | $1000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | $822000 | $15.9M | $14.6M | $13.5M | $12.4M | $22.0M | $19.1M | $17.3M | $15.4M | $1.1M |
| Actifs Totaux | $35.5M | $35.9M | $28.2M | $21.2M | $23.1M | $58.1M | $35.9M | $28.1M | $21.6M | $6.1M |
| Dettes Fournisseurs | $512000 | $1.2M | $1.4M | $1.1M | $1.7M | $1.9M | $1.5M | $857000 | $4.5M | $5.6M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | $1.8M | $1.8M | $634000 | $396000 |
| Passifs Courants | $1.4M | $5.4M | $3.9M | $2.2M | $5.1M | $8.3M | $6.7M | $7.6M | $25.8M | $14.1M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $1.6M | $10.6M | $8.9M | $7.0M | $8.9M | $20.2M | $17.6M | $16.0M | $31.6M | $14.4M |
| Réserves | -$160.5M | -$171.0M | -$14.6M | -$24.9M | -$36.2M | -$44.2M | -$68.6M | -$89.1M | -$115.1M | -$134.8M |
| Capitaux Propres | $33.9M | $25.3M | $19.2M | $14.2M | $14.1M | $37.9M | $18.3M | $12.1M | -$10.0M | -$8.3M |
| Dette Totale | $10000 | $10000 | $84000 | 0 | 0 | 0 | $1.8M | $1.8M | $634000 | $396000 |
| Dette Nette | -$33.4M | -$14.4M | -$5.9M | -$5.5M | -$8.8M | -$27.6M | -$5.5M | -$3.4M | -$1.0M | -$3.9M |
| Fonds de Roulement | $32.7M | $14.1M | $5.4M | $5.3M | $5.6M | $21.1M | $2.7M | $3.2M | -$19.7M | -$9.1M |
Santé financière
| Dette / Capitaux propres | 0.00 |
| Ratio de liquidité | 2.87 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -40.25 |
Rentabilité
| Rentabilité des capitaux propres | -116.86% |
| Rentabilité du capital investi | -36.21% |
| Rentabilité des actifs | -31.35% |
| Marge brute | 100.00% |
| Marge opérationnelle | -92086.45% |
| Marge nette | -113004.58% |
Entreprises liées: BDRX · CANF · CMND · CNSP · GRI · INM · OGEN
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de KZIA: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions